A study published in the New England Journal of Medicine found ozanimod, a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. William J. Sandborn, MD, chief of ...
Credit: Getty Images Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis. Ulcerative colitis (UC) is a chronic and relapsing type of ...
Bristol Myers Squibb today announced new post hoc analyses from the Phase 3 True North study evaluating the duration of response following continuous Zeposia treatment for up to one year and following ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results